New epilepsy drug shows promise in Long-Term safety trial
NCT ID NCT07238868
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational drug called CB03-154 in 144 people with focal epilepsy. Participants take the drug for up to two years to see if it is safe and helps reduce seizures. The goal is to find a better long-term treatment option for epilepsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CB03-154
What this could lead to
If successful, this could provide a new long-term treatment option to reduce seizure frequency in people with focal epilepsy.
What could go wrong
This is an early Phase 2 open-label study, so results may not confirm effectiveness. Side effects or lack of seizure control could limit its use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Health
RECRUITINGMelbourne, Victoria, 3004, Australia